532 related articles for article (PubMed ID: 27526014)
1. [New developments in molecular diagnostics of carcinomas of the salivary glands: "translocation carcinomas"].
Skálová A; Šteiner P; Vaneček T
Cesk Patol; 2016; 52(3):139-45. PubMed ID: 27526014
[TBL] [Abstract][Full Text] [Related]
2. Translocation-associated salivary gland tumors: a review and update.
Weinreb I
Adv Anat Pathol; 2013 Nov; 20(6):367-77. PubMed ID: 24113307
[TBL] [Abstract][Full Text] [Related]
3. Molecular Pathology of Salivary Gland Neoplasms: Diagnostic, Prognostic, and Predictive Perspective.
Toper MH; Sarioglu S
Adv Anat Pathol; 2021 Mar; 28(2):81-93. PubMed ID: 33405400
[TBL] [Abstract][Full Text] [Related]
4. An update on molecular diagnostics of squamous and salivary gland tumors of the head and neck.
Hunt JL
Arch Pathol Lab Med; 2011 May; 135(5):602-9. PubMed ID: 21526958
[TBL] [Abstract][Full Text] [Related]
5. The Role of Molecular Testing in the Differential Diagnosis of Salivary Gland Carcinomas.
Skálová A; Stenman G; Simpson RHW; Hellquist H; Slouka D; Svoboda T; Bishop JA; Hunt JL; Nibu KI; Rinaldo A; Vander Poorten V; Devaney KO; Steiner P; Ferlito A
Am J Surg Pathol; 2018 Feb; 42(2):e11-e27. PubMed ID: 29076877
[TBL] [Abstract][Full Text] [Related]
6. Utility of mammaglobin immunohistochemistry as a proxy marker for the ETV6-NTRK3 translocation in the diagnosis of salivary mammary analogue secretory carcinoma.
Bishop JA; Yonescu R; Batista D; Begum S; Eisele DW; Westra WH
Hum Pathol; 2013 Oct; 44(10):1982-8. PubMed ID: 23773480
[TBL] [Abstract][Full Text] [Related]
7. Fusion oncogenes in salivary gland tumors: molecular and clinical consequences.
Stenman G
Head Neck Pathol; 2013 Jul; 7 Suppl 1(Suppl 1):S12-9. PubMed ID: 23821214
[TBL] [Abstract][Full Text] [Related]
8. [Advances in genetics and pathology of salivary gland tumors].
Gao Y
Zhonghua Kou Qiang Yi Xue Za Zhi; 2012 Apr; 47(4):193-8. PubMed ID: 22800695
[No Abstract] [Full Text] [Related]
9. Reevaluation of MAML2 fusion-negative mucoepidermoid carcinoma: a subgroup being actually hyalinizing clear cell carcinoma of the salivary gland with EWSR1 translocation.
Hsieh MS; Wang H; Lee YH; Ko JY; Chang YL
Hum Pathol; 2017 Mar; 61():9-18. PubMed ID: 27769871
[TBL] [Abstract][Full Text] [Related]
10. New developments in the molecular pathogenesis of head and neck tumors: a review of tumor-specific fusion oncogenes in mucoepidermoid carcinoma, adenoid cystic carcinoma, and NUT midline carcinoma.
Bhaijee F; Pepper DJ; Pitman KT; Bell D
Ann Diagn Pathol; 2011 Feb; 15(1):69-77. PubMed ID: 21238915
[TBL] [Abstract][Full Text] [Related]
11. Current diagnosis and treatment of salivary gland-type tumors of the lung.
Horio Y; Kuroda H; Masago K; Matsushita H; Sasaki E; Fujiwara Y
Jpn J Clin Oncol; 2024 Mar; 54(3):229-247. PubMed ID: 38018262
[TBL] [Abstract][Full Text] [Related]
12. Molecular signature of salivary gland tumors: potential use as diagnostic and prognostic marker.
Fonseca FP; Sena Filho M; Altemani A; Speight PM; Vargas PA
J Oral Pathol Med; 2016 Feb; 45(2):101-10. PubMed ID: 25990369
[TBL] [Abstract][Full Text] [Related]
13. Expression of ras-P21 in salivary gland tumors.
Kusama K; Chu L; Suzuki T; Okutsu S; Kudo I; Moro I
Adv Exp Med Biol; 1995; 371B():1187-90. PubMed ID: 7502781
[No Abstract] [Full Text] [Related]
14. Salivary gland cancers: biology and molecular targets for therapy.
Bell D; Hanna EY
Curr Oncol Rep; 2012 Apr; 14(2):166-74. PubMed ID: 22246609
[TBL] [Abstract][Full Text] [Related]
15. Mammaglobin and S-100 immunoreactivity in salivary gland carcinomas other than mammary analogue secretory carcinoma.
Patel KR; Solomon IH; El-Mofty SK; Lewis JS; Chernock RD
Hum Pathol; 2013 Nov; 44(11):2501-8. PubMed ID: 24029710
[TBL] [Abstract][Full Text] [Related]
16. Clear Cell Neoplasms of Salivary Glands: A Diagnostic Challenge.
Skalova A; Leivo I; Hellquist H; Simpson RHW; Vander Poorten V; Willems SM; Mosaieby E; Slouka D; Ferlito A
Adv Anat Pathol; 2022 Jul; 29(4):217-226. PubMed ID: 35249992
[TBL] [Abstract][Full Text] [Related]
17. [A new analysis tool of salivary gland tumors: looking for specific translocations].
Uro-Coste E
Ann Pathol; 2011 Nov; 31(5 Suppl):S100-2. PubMed ID: 22054439
[No Abstract] [Full Text] [Related]
18. Pan-Trk immunohistochemistry reliably identifies ETV6-NTRK3 fusion in secretory carcinoma of the salivary gland.
Bell D; Ferrarotto R; Liang L; Goepfert RP; Li J; Ning J; Broaddus R; Weber RS; El-Naggar AK
Virchows Arch; 2020 Feb; 476(2):295-305. PubMed ID: 31423558
[TBL] [Abstract][Full Text] [Related]
19. [Molecular markers in salivary gland tumors: their use in diagnostic and prognostic workup].
Fehr A; Stenman G; Bullerdiek J; Löning T
Pathologe; 2009 Nov; 30(6):466-71. PubMed ID: 19784654
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic utility of phosphorylated signal transducer and activator of transcription 5 immunostaining in the diagnosis of mammary analogue secretory carcinoma of the salivary gland: A comparative study of salivary gland cancers.
Kawahara A; Taira T; Abe H; Takase Y; Kurita T; Sadashima E; Hattori S; Imamura I; Matsumoto S; Fujisaki H; Sueyoshi K; Akiba J; Kage M
Cancer Cytopathol; 2015 Oct; 123(10):603-11. PubMed ID: 26252941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]